Mode
Text Size
Log in / Sign up

Mediterranean and DASH diets consistently support mitigation of cardiometabolic risk in metabolic syndrome patientsMediterranean and DASH Diets Show Promise for Heart Health

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider Mediterranean and DASH diets as the most consistently supported dietary patterns for mitigating cardiometabolic risk.

This narrative review synthesizes current evidence regarding the impact of various dietary patterns on cardiometabolic risk (CKM) in patients with Metabolic Syndrome, Type 2 Diabetes Mellitus, and Chronic Kidney Disease. The authors evaluate Mediterranean, DASH, plant-based, and ketogenic diets as primary interventions for managing these conditions.

The review finds that Mediterranean and DASH diets are the most consistently supported dietary patterns for CKM risk mitigation. In contrast, the impact of plant-based diets is described as quality-dependent; healthful patterns are associated with improved cardiorenal outcomes, while unhealthful patterns may exacerbate metabolic derangements. The ketogenic diet shows mixed results, potentially improving glucose metabolism in the short term but raising concerns regarding elevated LDL cholesterol, potential hepatotoxicity, and limited long-term adherence.

A primary limitation noted is the difficulty of maintaining a ketogenic diet as a sustained long-term pattern. Clinicians should consider Mediterranean and DASH diets as consistently supported options while noting that the benefits of plant-based diets depend heavily on the nutritional quality of the food choices.

How this fits prior evidence

This review addresses gaps in dietary management for metabolic syndrome and cardiovascular disease. It complements existing evidence regarding ultra-processed food consumption being associated with higher risk of hypertension and cardiovascular disease by providing specific, high-quality alternatives like Mediterranean and DASH diets. While previous findings highlighted risks from processed foods, this synthesis identifies specific patterns that may mitigate cardiometabolic risk.

Researchers reviewed different dietary patterns to see how they affect metabolic syndrome, type 2 diabetes, and chronic kidney disease. The review looked at how these diets impact cardiovascular risk, blood sugar, and cholesterol levels.

The findings show that the Mediterranean and DASH diets are the most consistently supported for reducing heart health risks. While plant-based diets can be helpful, their benefits depend on the quality of the food. Healthy plant-based patterns may improve outcomes, while unhealthy options could make metabolic issues worse.

A ketogenic diet may help with blood sugar in the short term, but it has some drawbacks. It is linked to higher cholesterol and potential liver concerns, and many people find it hard to stick to over a long period. Because this was a review of existing literature rather than a new clinical trial, these results show general trends rather than specific medical guarantees.

What this means for you:
Mediterranean and DASH diets are consistently supported for heart health, while other diets have mixed results.

Common questions

Which diets are most effective for heart health?

The Mediterranean and DASH diets are the most consistently supported dietary patterns for mitigating risk of cardiovascular and metabolic issues. These plans are highlighted as reliable options for managing conditions like type 2 diabetes and chronic kidney disease.

Are all plant-based diets healthy?

Not all plant-based diets have the same effect. Healthy, high-quality plant-based patterns are associated with better heart and kidney outcomes. However, unhealthful plant-based patterns may actually make metabolic problems worse.

What are the risks of a ketogenic diet?

A ketogenic diet may improve glucose metabolism in the short term. However, it is associated with concerns regarding elevated LDL cholesterol and potential liver issues. Additionally, many people find it difficult to maintain as a long-term eating habit.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedJul 2026
View Original Abstract ↓
Driven by the global rise in obesity and lifestyle transitions, cardiovascular-kidney-metabolic (CKM) syndrome has emerged as a pathophysiological continuum characterized by metabolic dysregulation and involving multi-organ interactions. Within the comprehensive management of CKM syndrome, dietary patterns represent a cornerstone of intervention due to their high modifiability and cost-effectiveness. Adopting the perspective of the CKM syndrome pathophysiological continuum, this narrative review provides a thematic overview of the current literature on the Mediterranean, DASH, plant-based, and ketogenic diets in relation to metabolic syndrome, type 2 diabetes mellitus, chronic kidney disease, and cardiovascular disease. Evidence indicates that the Mediterranean and DASH diets, through established anti-inflammatory, antioxidant, and endothelial protective mechanisms, are the most consistently supported dietary patterns for CKM risk mitigation. The efficacy of plant-based diets is strictly quality-dependent: while healthful patterns rich in whole grains and vegetables are associated with improved cardiorenal outcomes, unhealthful patterns dominated by refined carbohydrates may exacerbate metabolic derangements. Although the ketogenic diet may improve glucose metabolism in the short term, concerns regarding elevated low-density lipoprotein cholesterol, potential hepatotoxicity, and limited long-term adherence suggest that its role may be more relevant in selected short-term settings than as a sustained long-term dietary pattern. Furthermore, structured dietary quality indices may provide useful tools for characterizing dietary exposure in relation to CKM and for generating mechanistic hypotheses. By integrating clinical and mechanistic evidence, this review outlines a stage-oriented conceptual framework to discuss how different dietary patterns may relate to distinct phases of the CKM syndrome.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.